Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Total Liabilities (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Total Liabilities readings, the most recent being $134.9 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 17.74% to $134.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $134.9 million, a 17.74% increase, with the full-year FY2025 number at $149.7 million, up 20.95% from a year prior.
  • Total Liabilities hit $134.9 million in Q1 2026 for Catalyst Pharmaceuticals, down from $149.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $149.7 million in Q4 2025 to a low of $26.2 million in Q2 2022.
  • Median Total Liabilities over the past 5 years was $85.3 million (2024), compared with a mean of $90.9 million.
  • The widest YoY moves for Total Liabilities: up 175.0% in 2023, down 2.52% in 2023.
  • Catalyst Pharmaceuticals' Total Liabilities stood at $75.2 million in 2022, then increased by 9.34% to $82.2 million in 2023, then soared by 50.52% to $123.8 million in 2024, then grew by 20.95% to $149.7 million in 2025, then decreased by 9.88% to $134.9 million in 2026.
  • The last three reported values for Total Liabilities were $134.9 million (Q1 2026), $149.7 million (Q4 2025), and $131.4 million (Q3 2025) per Business Quant data.